latest news releases from the newsroom
Seeger Weiss LLP
$20 Million Jury Verdict Rendered Against Merck & Co. in the Retrial of the Vioxx-Related Action Entitled, Humeston v. Merck
NEW YORK, March 12, 2007 (PRIME NEWSWIRE) -- Seeger Weiss LLP announces that a jury in Atlantic County, N.J. today returned a verdict awarding a total of $20 million in compensatory damages to plaintiff Frederick "Mike" Humeston and his wife Mary against defendant Merck & Co. (NYSE:MRK) in the Vioxx-related personal injury trial entitled, Humeston v. Merck. Last August, New Jersey Superior Court Judge Carol E. Higbee vacated the November 2005 verdict that had been rendered in Merck's favor in the original trial of the action on various grounds, including findings by the New England Journal of Medicine that Merck had failed to report material cardiovascular safety data in connection with the publication of its landmark 2000 Vioxx clinical study know as VIGOR. The retrial of the case began in January 2007. On March 2, 2007, the jury returned a verdict in the retrial's first phase, finding that Merck had failed to adequately warn of the cardiovascular safety risks posed by Vioxx. The trial then moved into its second phase, in which the jury heard evidence specifically relating to Mr. Humeston. Following the completion of the trial's second phase, the jury concluded that Vioxx use by Mr. Humeston, a decorated Vietnam War veteran, had resulted in his September 2001 heart attack and awarded $18 million in compensatory damages to Mr. Humeston and $2 million to his wife. Seeger Weiss LLP's trial team was led by partners Christopher A. Seeger, David R. Buchanan, and Moshe E. Horn. In response to today's jury verdict, Mr. Seeger stated: "We're very pleased that, after hearing all of the testimony and reviewing all of the documents, the jury recognized the very serious heart risks of Vioxx, risks that Merck went to great lengths to conceal from doctors and the public. This drug caused Mr. Humeston and many other people who relied on it for severe pain relief to suffer heart attacks or other serious cardiovascular side effects. This verdict today finally achieves justice for Mr. Humeston and his family, who were among the many thousands of unsuspecting users of this very dangerous product." The Atlantic County jury will now hear further evidence and arguments and then determine whether to award punitive damages.
UniTech Selects Tribeworks Subsidiary AtlasTG
GZIRA, Republic of Malta, March 12, 2007 (PRIME NEWSWIRE) -- Tribeworks, Inc. (OTCBB:TWKS) announced that its primary operating subsidiary, Atlas Technology Group, has signed Universal Information Technology Group, Ltd. (UniTech) as a UK Onboarding Partner for software services and support.
uBid.com Holdings, Inc.
uBid.com Holdings, Inc. Announces New Appointments and Changes in Its Board of Directors
CHICAGO, March 12, 2007 (PRIME NEWSWIRE) -- uBid.com Holdings, Inc. (OTCBB:UBHI) whose uBid, Inc. subsidiary is one of the leading business-to-consumer and business-to-business online marketplaces in the U.S., today announced the appointment of Mary Jeffries, President & COO of Petters Group Worldwide and David Baer, Chief Legal Officer of Petters Group Worldwide to its Board of Directors. These appointments replace Stuart Romenesko and Paul Traub who tendered their resignation as Directors. Their resignations became effective immediately prior to the appointments of the new Directors.